Clinical Trial Update: A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing bevacizumab with extended temozolomide in patients with recurrent glioblastoma; the study has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• Temodar (Temozolomide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2014-12-08